3M acquires Zargis's heart diagnostic tech
This article was originally published in Clinica
Executive Summary
3M Health Care has acquired certain assets of Zargis Medical relating to its Cardioscan software, which helps identify and classify suspected heart murmurs. Financial terms of the deal were not disclosed. Specifically, the deal includes Cardioscan, which was cleared by the US FDA in 2004 and by Health Canada in January 2010 (www.clinica.co.uk, 11 January 2010), as well as Zargis's TeleSteth and StethAssist software. The former is an online tele-ausculation (listening with a stethoscope) product which allows healthcare professionals to share internal sounds with colleagues over the internet, while StethAssist is used with electronic stethoscopes to record and display these acoustic signals. 3M and Zargis already had a partnership in which the former's Littmann Model 3200 stethoscope was used in combination with the latter's software.